EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C10H16ClN7O |
| Net Charge | 0 |
| Average Mass | 285.739 |
| Monoisotopic Mass | 285.11049 |
| SMILES | CCCN(C)c1nc(N)c(C(=O)NC(=N)N)nc1Cl |
| InChI | InChI=1S/C10H16ClN7O/c1-3-4-18(2)8-6(11)15-5(7(12)16-8)9(19)17-10(13)14/h3-4H2,1-2H3,(H2,12,16)(H4,13,14,17,19) |
| InChIKey | HDJJAWCPAZTZIG-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Role: | sodium channel blocker An agent that inhibits sodium influx through cell membranes. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 5-(N-methyl-N-propyl)amiloride (CHEBI:138016) has functional parent amiloride (CHEBI:2639) |
| 5-(N-methyl-N-propyl)amiloride (CHEBI:138016) has role sodium channel blocker (CHEBI:38633) |
| 5-(N-methyl-N-propyl)amiloride (CHEBI:138016) is a guanidines (CHEBI:24436) |
| 5-(N-methyl-N-propyl)amiloride (CHEBI:138016) is a organochlorine compound (CHEBI:36683) |
| 5-(N-methyl-N-propyl)amiloride (CHEBI:138016) is a primary amino compound (CHEBI:50994) |
| 5-(N-methyl-N-propyl)amiloride (CHEBI:138016) is a pyrazines (CHEBI:38314) |
| 5-(N-methyl-N-propyl)amiloride (CHEBI:138016) is a tertiary amino compound (CHEBI:50996) |
| IUPAC Name |
|---|
| 3-amino-N-carbamimidoyl-6-chloro-5-[methyl(propyl)amino]pyrazine-2-carboxamide |
| Synonyms | Source |
|---|---|
| 3-amino-N-(aminoiminomethyl)-6-chloro-5-(methylpropylamino)-pyrazinecarboxamide | ChemIDplus |
| 5-N-Mpa | ChemIDplus |
| MPA | ChEBI |
| 5-N-MPA | ChEBI |
| Registry Numbers | Sources |
|---|---|
| Reaxys:548085 | Reaxys |
| CAS:1151-75-3 | ChemIDplus |